Congrats to Elham Azizi on this richly deserved award!

These are welcome findings that prophy metformin can prevent alpelisib induced hyperglycemia. But it’s unfortunate these data are obtained 5 years after alpelisib FDA approval. We need better AE management strategies built into trials. PIK3CA Path Breakers #bcsm

What an incredible woman whose fervor transformed all around her. We will honor your memory.

How is the Oncologic Drugs Advisory Committee an integral part of the FDA assessment? Click to watch the replay of a #ConversationsonCancer panel discussion, 'ODAC Chronicles - Past, Present, & Future of Oncology Advisory Committees.' #OCEProjectCommunity

youtube.com/live/MNZhNkt-x…

Of all the papers I have read in the last year this wins the 🤯🤯🤯 award. It’s also gorgeously and rigorously proven. nature.com/articles/s4158…

Congrats Ken and team!

Congratulations Dr. Rustgi on this richly deserved award. Your talk was inspiring and we are thrilled have your leadership. Herbert Irving Comprehensive Cancer Center

Congrats Bart and Roger, this is so well deserved!

Join us at 930 AM today for a discussion on ODAC. Looking forward to being on this panel with past and present ODAC members! OncoAlert #bcsm Herbert Irving Comprehensive Cancer Center

Congrats to Anil K. Rustgi on this richly deserved award. We are privileged to have you leading Herbert Irving Comprehensive Cancer Center!

Great to be part of this group and thanks to VIRGINIA KAKLAMANI Carlos L. Arteaga, M.D. for their leadership. Looking forward to #SABCS2024 !

Congrats to Aaron Viny on this award!

Congrats to Benjamin Herzberg for leading this critical effort to expand clinical trials enrollment. Columbia Medicine Herbert Irving Comprehensive Cancer Center

This is a fundamental paper that has changed the way I think about oncogenesis. A must read.

A fantastic opportunity to work with an innovative and generous mentor at the cutting edge of cancer immunology and cell biology!

Congrats to bizarMD on this impactful study showing the role of PIP4K2C in melanoma liver metastasis. Very exciting to see functional work on “alternative” lipid kinases in cancer.

This is a fascinating and important study in young women showing an increase in rates of ER+ breast tumors across all races. Interestingly decrease in ER- tumors. This will spur important research questions into etiology and screening. #bcsm OncoAlert PIK3CA Path Breakers

This is a welcome recommendation to liberalize germline genetic testing for all pts with BC < age 65 regardless of receptor subtype, and pts > age 65 with family hx. Hoping other organizations will harmonize guidelines which will help patients and clinicians. #bcsm

Congrats to Ralitsa Madsen CellSig_Lab for this provocative and rigorous study of PIK3CA mutations and PI3K signaling. This work turns a lot of assumptions we have about signaling on their head and is an exciting direction for the field!

Thank you to NewYork-Presbyterian for the writeup about our lab's work on PI3K and for all your support in our care for breast cancer patients! Herbert Irving Comprehensive Cancer Center
nyp.org/advances/explo…